REGISTERED NUMBER: 14435757 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 October 2025

for

RCFE Medical Ltd

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

34,157

45,048

CURRENT ASSETS

Debtors

5

9,172

26,248

Cash at bank

23,940

9,423

33,112

35,671

CREDITORS

Amounts falling due within one year

6

28,292

29,512

NET CURRENT ASSETS

4,820

6,159

TOTAL ASSETS LESS CURRENT LIABILITIES

38,977

51,207

CREDITORS

Amounts falling due after more than one year

7

(32,112

)

(39,850

)

PROVISIONS FOR LIABILITIES

(6,489

)

(11,262

)

NET ASSETS

376

95

CAPITAL AND RESERVES

Called up share capital

90

90

Retained earnings

286

5

SHAREHOLDERS' FUNDS

376

95

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 July 2026 and were signed on its behalf by:

Mr R X Nolan - Director

1.	STATUTORY INFORMATION

RCFE Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

14435757

Registered office:

14 Teddy Gray Avenue

Elworth

Sandbach

Cheshire

CW11 3AR

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Equipment

-

25% on reducing balance

Motor vehicles

-

25% on reducing balance

Computer equipment

-

Straight line over 3 years

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheetbalance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Motor

Computer

Equipment

vehicles

equipment

Totals

£

£

£

£

COST

At 1 November 2024

-

65,405

3,315

68,720

Additions

681

-

1,032

1,713

At 31 October 2025

681

65,405

4,347

70,433

DEPRECIATION

At 1 November 2024

-

21,461

2,211

23,672

Charge for year

170

10,986

1,448

12,604

At 31 October 2025

170

32,447

3,659

36,276

NET BOOK VALUE

At 31 October 2025

511

32,958

688

34,157

At 31 October 2024

-

43,944

1,104

45,048

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Motor

vehicles

£

COST

At 1 November 2024

and 31 October 2025

65,405

DEPRECIATION

At 1 November 2024

21,461

Charge for year

10,986

At 31 October 2025

32,447

NET BOOK VALUE

At 31 October 2025

32,958

At 31 October 2024

43,944

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

9,172

26,248

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Hire purchase contracts

7,738

7,738

Taxation and social security

18,231

19,737

Other creditors

2,323

2,037

28,292

29,512

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Hire purchase contracts

32,112

39,850

8.	SECURED DEBTS

The following secured debts are included within creditors:

2025

2024

£

£

Hire purchase contracts

39,850

47,588

The hire purchase is secured against the asset to which it relates.

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2025 and 31 October 2024:

2025

2024

£

£

Mr R X Nolan

Balance outstanding at start of year

25,124

2,346

Amounts advanced

10,999

24,627

Amounts repaid

(26,951

)

(1,849

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

9,172

25,124